NASDAQ:GLTO

Galecto, Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.700

-0.0169 (-2.36%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for GLTO

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	0.753	7.59 %
		R2	0.738	5.41 %
		R1	0.729	4.07 %
Current price:			0.700
	Support	S1	0.698	-0.287 %
		S2	0.689	-1.63 %
		S3	0.673	-3.81 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0.87	24.24 %
		R2	0.82	17.13 %
		R1	0.780	11.41 %
Current price			0.700
	Support	S1	0.692	-1.23%
		S2	0.681	-2.73%
		S3	0.600	-14.28%

GLTO Predictions History

1 year ago
frank273333 predicted that GLTO for 2023-03-03 is going

Rank:

About Galecto, Inc.

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a ... GLTO Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In